Published in Vaccine Weekly, September 27th, 2000
"A vaccination protocol for advanced melanoma and renal cell carcinoma with DC pulsed with HSP obtained from autologous tumor tissue was planned in the Department of Medical Oncology, Forli," reported Angela Riccobon and colleagues from Pierantoni Hospital and the Institute Oncologico Romagnolo. "DC were differentiated from peripheral blood lymphocytes (PBL) obtained by leukapheresis without pharmacological stimulation immediately before the first treatment cycle."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.